Siltuximab in Schizophrenia

Clinical trial NCT02796859 · UNKNOWN

Trial details

NCT number: NCT02796859
Sponsor: Brian Miller
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorders

Start date: 2016-05-01
Primary completion: 2023-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.